0001062993-24-003329.txt : 20240215 0001062993-24-003329.hdr.sgml : 20240215 20240215172539 ACCESSION NUMBER: 0001062993-24-003329 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240213 FILED AS OF DATE: 20240215 DATE AS OF CHANGE: 20240215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hahne Vicky CENTRAL INDEX KEY: 0001716043 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38207 FILM NUMBER: 24644936 MAIL ADDRESS: STREET 1: C/O CELCUITY, 16305 36TH AVENUE N. STREET 2: #450 CITY: MINNEAPOLIS STATE: MN ZIP: 55446 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celcuity Inc. CENTRAL INDEX KEY: 0001603454 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 16305 36TH AVENUE N STREET 2: SUITE 100 CITY: MINNEAPOLIS STATE: MN ZIP: 55446 BUSINESS PHONE: 763-392-0767 MAIL ADDRESS: STREET 1: 16305 36TH AVENUE N STREET 2: SUITE 100 CITY: MINNEAPOLIS STATE: MN ZIP: 55446 FORMER COMPANY: FORMER CONFORMED NAME: Celcuity LLC DATE OF NAME CHANGE: 20140324 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2024-02-13 0001603454 Celcuity Inc. CELC 0001716043 Hahne Vicky 16305 36TH AVENUE N. SUITE 100 MINNEAPOLIS MN 55446 0 1 0 0 Chief Financial Officer 0 Common Stock 16557 D Stock Option (right to buy) 8.4000 2027-05-17 Common Stock 37500 37500 D Stock Option (right to buy) 5.50 2028-07-05 Common Stock 3000 3000 D Stock Option (right to buy) 5.50 2028-10-17 Common Stock 932 932 D Stock Option (right to buy) 5.50 2029-08-12 Common Stock 3000 3000 D Stock Option (right to buy) 5.9000 2030-08-12 Common Stock 10000 10000 D Stock Option (right to buy) 5.50 2030-12-28 Common Stock 1122 1122 D Stock Option (right to buy) 5.50 2031-02-02 Common Stock 1301 1301 D Stock Option (right to buy) 5.50 2031-03-18 Common Stock 1204 1204 D Stock Option (right to buy) 5.50 2031-04-12 Common Stock 3806 3806 D Stock Option (right to buy) 5.50 2031-08-11 Common Stock 15000 15000 D Stock Option (right to buy) 5.50 2031-10-27 Common Stock 821 821 D Stock Option (right to buy) 5.50 2032-05-17 Common Stock 31930 31930 D Stock Option (right to buy) 11.55 2033-02-16 Common Stock 5069 5069 D Stock Option (right to buy) 9.89 2033-08-25 Common Stock 21250 21250 D Stock Option (right to buy) 9.89 2033-08-25 Common Stock 60000 60000 D Stock Option (right to buy) 15.03 2024-02-13 4 A 0 5530 0 A 2034-02-13 Common Stock 5530 5530 D Includes 2,000 shares acquired on October 31, 2023 pursuant to the Issuer's Employee Stock Purchase Plan. Fully vested. 2,500 shares vest on 8/12/21; the remaining 7,500 shares vest 1/36th per month thereafter. 280 shares vest on 12/29/21; the remaining 842 shares vest 1/36th per month thereafter. 325 shares vest on 2/2/22; the remaining 976 shares vest 1/36th per month thereafter. 301 shares vest on 3/18/22; the remaining 903 shares vest 1/36th per month thereafter. 952 shares vest on 4/12/22; the remaining 2,854 shares vest 1/36th per month thereafter. 3,750 shares vest on 8/11/22; the remaining 11,250 shares vest 1/36th per month thereafter. 205 shares vest on 10/27/22; the remaining 616 shares vest 1/36th per month thereafter. These shares vest in equal amounts on the last day of each month over seventeen (17) months, beginning August 31, 2023. 15,000 shares vest on 8/25/24; the remaining 45,000 shares vest 1/36th per month thereafter. These shares vest in equal amounts on the first day of each month over twelve (12) months, beginning March 1, 2024 /s/ Eric O. Madson as Attorney-in-Fact for Vicky Hahne pursuant to Power of Attorney previously filed. 2024-02-15